Roundup was a herbicide manufactured by Monsanto, a company that was acquired by Bayer in 2018 for $63 bllion. It was by far the most popular herbicide on the U.S. market, with over 75 percent market share. In 2023, Monsanto discontinued selling Roundup.

The key ingredient of Roundup was glyphosate, a chemical that the International Agency of Research on Cancer (“IARC”) has classified as “possibly carcinogenic to humans.” Specifically, individuals exposed to Roundup over several years run a significant risk of contracting non-Hodgkin’s lymphoma.

Paragon is aware of seven substantial verdicts in favor of plaintiffs that have sued Monsanto for the harm they have suffered from their use of Roundup:

It’s important to note, of course, that Monsanto has won many of the lawsuits filed by other plaintiffs, and that for some of the cases listed above, it’s possible that Monsanto will prevail on appeal.

Around October 2023, Monsanto reached an approximately $11 billion settlement with most plaintiffs, and approximately 80 percent of Roundup claims have been settled. Given the long latency of non-Hodgkin’s lymphoma, Roundup will be a viable case type for at least the next decade.